The relationship between physicians and pharmacy benefit managers continues to change. A goal of Prescription Solutions' Brian Solow, MD, is to foster a collaborative approach to working with physicians, to ultimately deliver better care to patients.
During his tenure with Bristol Park Medical Group, a physician-owned primary care group in Irvine, he participated on multiple leadership committees while maintaining a family medicine practice. Over the years, Dr. Solow has gained knowledge of the PBM industry as a member of the national pharmacy and therapeutics committees of various PBMs.
"I reach out to doctors and find out how we can become their partners and not interfere with their practices," Dr. Solow says. "We need them to recognize the true value of the PBM because a lot of physicians just see PBMs as another piece of the insurance puzzle. We know we can target the consumer, and the consumer can target the doctor. If we can get both parties onboard, we'll have better success implementing medi cation therapy management [MTM] and other clinical programs."
Q. What is your biggest challenge with managing pharmaceutical benefits?
We want them to understand that we are not trying to limit their utilization of medications, nor are we trying to limit choices, but rather are promoting the appropriateness of their prescription medications with a focus on the clinical quality. It's important that all stakeholders in the healthcare system work together to help patients lead healthy, productive lives.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More